- Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, launched a new cannabis education platform, WeCare-MedicalCannabis
- The platform provides resources and educates healthcare practitioners and patients about medical cannabis
- It is tailored for healthcare professionals, caregivers, and patients to help them make informed decisions about medicinal cannabis
- Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
- Tilray Stock (TSX:TLRY) is up 2.26 per cent, trading at C$4.52 per share at 12:13 pm ET
Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has launched a new cannabis education platform, WeCare-MedicalCannabis.
The platform provides resources and educates healthcare practitioners and patients about medical cannabis.
WeCare-MedicalCannabis has science and research-based cannabis content for healthcare professionals, caregivers, and patients to help them make informed decisions about medicinal cannabis. It assists them along their path to discovering how medicinal cannabis can support daily wellness and health.
The platform serves as a one-stop, comprehensive resource on medical cannabis insights. WeCare-MedicalCannabis is now available in Germany, France, the United Kingdom, and Portugal.
Sascha Mielcarek, Managing Director of Tilray Europe, commented on the news.
“As global pioneers in medical cannabis, we are aware of the lack of access to science-based, medical cannabis education. WeCare-MedicalCannabis aims to bridge that gap. As cannabis legalization continues to expand across Europe, Tilray Medical is dedicated to help provide informed and trusted guidance for those interested in learning more about medical cannabis.”
By providing access to educational platforms such as WeCare-MedicalCannabis, Tilray Medical continues to open and expand its world of wellbeing.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. The company is one of the biggest suppliers of medicinal cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.
